SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-16-000043
Filing Date
2016-07-05
Accepted
2016-07-05 16:18:03
Documents
3
Period of Report
2016-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvnc7520168k.htm 8-K 31568
2 EXHIBIT 99.1 rvnc752016ex991.htm EX-99.1 15876
3 GRAPHIC rvncnewlogoa08.jpg GRAPHIC 26009
  Complete submission text file 0001479290-16-000043.txt   84598
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 161750684
SIC: 2834 Pharmaceutical Preparations